Results 41 to 50 of about 1,090,016 (327)

Molecular profile of BRCA-mutated biliary tract cancers

open access: yesESMO Open, 2020
Introduction Prognosis of biliary tract cancers (BTC) remains dismal and novel treatment strategies are needed to improve survival. BRCA mutations are known to occur in BTC but their frequency and the molecular landscape in which they are observed in ...
G. Spizzo   +21 more
semanticscholar   +1 more source

Association Between Proton Pump Inhibitor Use and Biliary Tract Cancer Risk: A Swedish Population‐Based Cohort Study

open access: yesHepatology, 2021
Biliary tract cancer is a group of highly aggressive malignant disorders, yet risk factors are poorly understood. In this study, we aim to assess whether prolonged use of proton pump inhibitors (PPIs) increases the risk of incident biliary tract ...
Habiba Kamal   +3 more
semanticscholar   +1 more source

Hepatic progenitor cells from adult human livers for cell transplantation. [PDF]

open access: yes, 2008
Objective: Liver regeneration is mainly based on cellular self-renewal including progenitor cells. Efforts have been made to harness this potential for cell transplantation, but shortage of hepatocytes and premature differentiated progenitor cells ...
Aurich, H.   +10 more
core   +1 more source

Circulating Tumor DNA in Biliary Tract Cancer: Current Evidence and Future Perspectives

open access: yesCancer Genomics & Proteomics, 2020
Peripheral blood of cancer patients “physiologically” presents cells and cellular components deriving from primary or metastatic sites, including circulating tumor cells (CTCs), circulating free DNA (cfDNA) and exosomes containing proteins, lipids and ...
A. Rizzo   +3 more
semanticscholar   +1 more source

Incidence and Mortality of Cancers of the Biliary Tract, Gallbladder, and Liver by Sex, Age, Race/Ethnicity, and Stage at Diagnosis: United States, 2013 to 2017

open access: yesCancer Epidemiology, Biomarkers and Prevention, 2021
Background: Few population-based studies have examined incidence and mortality of cancers of the biliary tract, including intrahepatic bile duct, extrahepatic bile duct, ampulla of Vater, and overlapping or other lesions of the biliary tract in one study.
Taylor D. Ellington   +5 more
semanticscholar   +1 more source

Correlation of mechanical factors and gallbladder pain [PDF]

open access: yes, 2008
Acalculous biliary pain occurs in patients with no gallstones, but is similar to that experienced by patients with gallstones. Surgical removal of the gallbladder (GB) in these patients is only successful in providing relief of symptoms to about half of ...
Bird, N.C.   +6 more
core   +3 more sources

“Steinstrasse” in the Biliary Tract

open access: yesThe Eurasian Journal of Medicine, 2017
The presence of a stone or stones within the common bile duct (CBD) is known as choledocholithiasis. Choledocholithiasis is reported in 3%-22% of patients undergoing cholecystectomies [1]. A confirmatory diagnosis of choledocholithiasis is made using advanced imaging, including magnetic resonance cholangiopancreatography and endoscopic retrograde ...
openaire   +4 more sources

Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers: A Phase 2 Clinical Trial.

open access: yesJAMA Oncology, 2019
Importance Administration of gemcitabine-cisplatin, the current standard therapy for advanced biliary tract cancers, results in median progression-free survival and overall survival of 8.0 and 11.7 months, respectively.
R. Shroff   +12 more
semanticscholar   +1 more source

Immunotherapy in Advanced Biliary Tract Cancers

open access: yesCancers, 2021
Simple Summary A new era has emerged in oncology in the last ten years with the development of immune therapies. However, single-agent immune therapy such as immune checkpoint inhibitors seems to have a limited clinical activity in biliary tract cancers ...
A. Boilève   +5 more
semanticscholar   +1 more source

Fasting-induced RNF152 resensitizes gallbladder cancer cells to gemcitabine by inhibiting mTORC1-mediated glycolysis

open access: yesiScience
Summary: Abnormal mTORC1 activation by the lysosomal Ragulator complex has been implicated in cancer and glycolytic metabolism associated with drug resistance. Fasting upregulates RNF152 and mediates the metabolic status of cells.
Ying Tao   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy